Ethical Cultures in Corporations

Using a Q& A format from the moderator, the speaker will share a senior corporate leadership perspective on the importance of actively managing toward ethical culture in a large health care corporation. Additionally, the role of ethical culture in employee retention and creating long term strategic advantage will be discussed. Audience Q& A will follow the moderator's questions. 
 
Mr. Roy N. Davis was a senior executive with Johnson & Johnson (J&J) until his retirement in January of 2012. His last position was Corporate Vice President of Business Development for all of J&J worldwide. In this role, Mr. Davis was responsible for helping J&J to determine its new business creation and acquisition strategy as a global corporation.

As part of this role he was also President of Johnson & Johnson Development Corporation (J&J’s venture capital group) and had full responsibility for J&J’s extensive venture investment portfolio as a global corporation. Concurrently, Mr. Davis was also the leader of the Johnson & Johnson wholly owned ventures group as well as the creator of Red Script Ventures, LLC (J&J's business accelerator).

From September of 2003 until the end of 2007, Mr. Davis held the position of Company Group Chairman, Johnson & Johnson and Worldwide Franchise Chairman, Medical Diagnostics. He was a member of J&J's Medical Devices & Diagnostics Group Operating Committee, which oversees one of the world's largest medical device businesses with over $30 Billion in revenue and over 40,000 employees. Prior to being named Company Group Chairman, Mr. Davis served J&J as Group President for Therakos Inc, Virco BVBA and Veridex LLC, he had founded Veridex as new company inside J&J in 2001. Veridex went on to produce products in cancer diagnostics that won awards from the Cleveland Clinic, Time Magazine and the United Kingdom for medical innovation.

In his earlier career with J&J, Mr. Davis was Managing Director, Northern Europe and in 1990 was named President in Japan, chairing the J&J Japan Presidents Council in 1991. 

Following his 28-year career with J&J, Mr. Davis has served as a member of the Innovations Advisory Board for the Cleveland Clinic for five years, the Advisory Board for the Wake Forest Institute for Regenerative Medicine for three years, Advisor to the strategy firm, Innosight Consulting in Lexington, MA since March of 2012, Advisor to Innosight’s parent company, Huron Consulting (HURN:NASDQ) since October 2017, Advisor and Board Member for several diagnostic start up companies(2013-2020), and guest lectured at Princeton University for three years in its Entrepreneurship program. 

Mr. Davis received a Bachelor of Science from the State University of New York and a Master of Science from Rensselaer Polytechnic Institute (RPI). Mr. Davis is also co-Chair, Rensselaer Greater NY Executive Council and a member of the Board of Trustees for RPI where he serves on both the Advancement and Investment(Endowment) committees. He also serves as a Board Member and Officer for the 135-year old Lake George Association (LGA) an environmental organization dedicated to clean fresh water. Additionally Mr. Davis chairs the Governance and Nominating Committee for the LGA. 

The webinar will be hosted by Azita Hirsa, Ph.D., a teaching professor at the Rensselaer Polytechnic Institute’s School of Engineering (Industrial Systems Engineering Department). She teaches courses in Management of Engineering and Technology, Ethics of Modeling, Engineering Ethics, and Professional Development: Technical Issues and Solutions. She is the Chair of the Ethics Division at the American Society of Engineering Education (ASEE).

Watch Here